# Oxaliplatine Based Adjuvant Chemotherapy for Stage II/III Colorectal Cancer: 8 Cycles Versus 12 Cycles

> **NCT00868816** · PHASE4 · COMPLETED · sponsor: **Fudan University** · enrollment: 400 (actual)

## Conditions studied

- Colorectal Cancer

## Interventions

- **DRUG:** 12 cycles of oxaliplatine based adjuvant chemotherapy
- **DRUG:** 8 cycles of oxaliplatine based adjuvant chemotherapy

## Key facts

- **NCT ID:** NCT00868816
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-01
- **Primary completion:** 2007-12
- **Final completion:** 2007-12
- **Target enrollment:** 400 (ACTUAL)
- **Last updated:** 2009-03-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00868816

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00868816, "Oxaliplatine Based Adjuvant Chemotherapy for Stage II/III Colorectal Cancer: 8 Cycles Versus 12 Cycles". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00868816. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*